A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Clinical trial NCT04093570 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT04093570
Sponsor: Taiho Oncology, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes

Start date: 2019-09-30
Primary completion: 2027-12-31
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.